Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,436 | 460 | 53.1% |
| Consulting Fee | $3,325 | 3 | 18.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,557 | 3 | 14.4% |
| Travel and Lodging | $2,127 | 10 | 12.0% |
| Education | $316.74 | 7 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $7,322 | 198 | $0 (2024) |
| Theratechnologies Inc. | $4,204 | 19 | $0 (2023) |
| ViiV Healthcare Company | $3,633 | 126 | $0 (2024) |
| Janssen Biotech, Inc. | $785.73 | 42 | $0 (2023) |
| Merck Sharp & Dohme LLC | $551.45 | 34 | $0 (2023) |
| Janssen Products, LP | $260.94 | 3 | $0 (2020) |
| ABBVIE INC. | $240.68 | 21 | $0 (2022) |
| GlaxoSmithKline, LLC. | $160.61 | 8 | $0 (2022) |
| Napo Pharmaceuticals Inc | $104.81 | 6 | $0 (2024) |
| EMD Serono, Inc. | $93.17 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,961 | 39 | ViiV Healthcare Company ($1,483) |
| 2023 | $2,758 | 67 | Theratechnologies Inc. ($1,197) |
| 2022 | $1,536 | 79 | Gilead Sciences, Inc. ($511.88) |
| 2021 | $1,125 | 59 | Gilead Sciences, Inc. ($523.65) |
| 2020 | $998.53 | 53 | Gilead Sciences, Inc. ($497.73) |
| 2019 | $1,581 | 93 | Gilead Sciences, Inc. ($784.12) |
| 2018 | $1,017 | 49 | Gilead Sciences, Inc. ($517.28) |
| 2017 | $6,785 | 44 | Gilead Sciences Inc ($3,464) |
All Payment Transactions
483 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.90 | General |
| 11/11/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: HIV | ||||||
| 08/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.56 | General |
| 08/21/2024 | ViiV Healthcare Company | — | Travel and Lodging | In-kind items and services | $248.65 | General |
| 08/21/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $99.26 | General |
| 08/21/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $80.79 | General |
| 08/21/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $46.11 | General |
| 08/21/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $43.86 | General |
| 08/20/2024 | ViiV Healthcare Company | — | Travel and Lodging | In-kind items and services | $275.94 | General |
| 08/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.25 | General |
| 08/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.52 | General |
| 07/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.75 | General |
| 07/25/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $120.87 | General |
| Category: HIV | ||||||
| 07/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.83 | General |
| 06/18/2024 | ViiV Healthcare Company | — | Travel and Lodging | In-kind items and services | $264.85 | General |
| 06/18/2024 | ViiV Healthcare Company | — | Travel and Lodging | In-kind items and services | $31.02 | General |
| 06/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.43 | General |
| 05/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.44 | General |
| 05/13/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: HIV | ||||||
| 04/22/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: HIV | ||||||
| 04/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.53 | General |
| 04/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.82 | General |
| 04/09/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: HIV | ||||||
| 04/05/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: HIV | ||||||
| 03/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.01 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 11 | 19 | $3,420 | $1,115 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 11 | 19 | $3,420 | $1,115 | 32.6% |
About Dr. Jerome De Vente, MD
Dr. Jerome De Vente, MD is a Infectious Disease healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548208242.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerome De Vente, MD has received a total of $17,762 in payments from pharmaceutical and medical device companies, with $1,961 received in 2024. These payments were reported across 483 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($9,436).
As a Medicare-enrolled provider, De Vente has provided services to 11 Medicare beneficiaries, totaling 19 services with total Medicare billing of $1,115. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Long Beach, CA
- Active Since 06/03/2006
- Last Updated 09/07/2007
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1548208242
Products in Payments
- TROGARZO (Drug) $1,152
- DOVATO (Drug) $1,115
- SYMTUZA (Drug) $632.79
- CABENUVA (Biological) $376.24
- PREZCOBIX (Drug) $348.59
- ISENTRESS (Drug) $313.01
- RUKOBIA (Drug) $311.71
- APRETUDE (Biological) $267.87
- PIFELTRO (Drug) $219.69
- TRIUMEQ (Drug) $217.97
- MAVYRET (Drug) $217.83
- EGRIFTA (Drug) $181.57
- SHINGRIX (Biological) $160.61
- JULUCA (Drug) $153.06
- Mytesi (Drug) $104.81
- Genvoya (Drug) $91.60
- Symtuza (Drug) $65.29
- TIVICAY (Drug) $54.99
- APTIMA (Device) $49.83
- CRESEMBA (Drug) $46.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Long Beach
Stefan Schneider, Md, MD
Infectious Disease — Payments: $279,134
Marcia Alcouloumre Senteno, Md, MD
Infectious Disease — Payments: $17,695
Dr. Greg Strayer, Md, MD
Infectious Disease — Payments: $6,385
Henry Su, M.d, M.D
Infectious Disease — Payments: $5,638
Melissa King, Md, MD
Infectious Disease — Payments: $495.18
Laurie Mortara, Md, MD
Infectious Disease — Payments: $159.73